These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29994606)

  • 1. Quantitative MRI Brain Studies in Mild Cognitive Impairment and Alzheimer's Disease: A Methodological Review.
    Leandrou S; Petroudi S; Kyriacou PA; Reyes-Aldasoro CC; Pattichis CS
    IEEE Rev Biomed Eng; 2018; 11():97-111. PubMed ID: 29994606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological Biomarker Differentiating MCI Converters from Nonconverters: Longitudinal Evidence Based on Hemispheric Asymmetry.
    Long X; Jiang C; Zhang L
    Behav Neurol; 2018; 2018():3954101. PubMed ID: 29755611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.
    Ruiz de Miras J; Costumero V; Belloch V; Escudero J; Ávila C; Sepulcre J
    Hum Brain Mapp; 2017 Dec; 38(12):5905-5918. PubMed ID: 28856799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.
    Ramírez J; Górriz JM; Ortiz A; Martínez-Murcia FJ; Segovia F; Salas-Gonzalez D; Castillo-Barnes D; Illán IA; Puntonet CG;
    J Neurosci Methods; 2018 May; 302():47-57. PubMed ID: 29242123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ensemble learning system for a 4-way classification of Alzheimer's disease and mild cognitive impairment.
    Yao D; Calhoun VD; Fu Z; Du Y; Sui J
    J Neurosci Methods; 2018 May; 302():75-81. PubMed ID: 29578038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models.
    Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L;
    Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of feature representations in MRI-based MCI-to-AD conversion prediction.
    Gómez-Sancho M; Tohka J; Gómez-Verdejo V;
    Magn Reson Imaging; 2018 Jul; 50():84-95. PubMed ID: 29530541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.
    Eskildsen SF; Coupé P; García-Lorenzo D; Fonov V; Pruessner JC; Collins DL;
    Neuroimage; 2013 Jan; 65():511-21. PubMed ID: 23036450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
    Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predication of different stages of Alzheimer's disease using neighborhood component analysis and ensemble decision tree.
    Jin M; Deng W
    J Neurosci Methods; 2018 May; 302():35-41. PubMed ID: 29486213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images.
    Garg N; Choudhry MS; Bodade RM
    J Neurosci Methods; 2023 Jan; 384():109745. PubMed ID: 36395961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting conversion from MCI to AD by integrating rs-fMRI and structural MRI.
    Hojjati SH; Ebrahimzadeh A; Khazaee A; Babajani-Feremi A;
    Comput Biol Med; 2018 Nov; 102():30-39. PubMed ID: 30245275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
    Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
    Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.